Longitudinal Examination of Abstinence Maintenance and Relapse in Cigarette Smokers

Information

  • Research Project
  • 10415782
  • ApplicationId
    10415782
  • Core Project Number
    R21DA048422
  • Full Project Number
    7R21DA048422-02
  • Serial Number
    048422
  • FOA Number
    PA-18-590
  • Sub Project Id
  • Project Start Date
    9/30/2020 - 4 years ago
  • Project End Date
    8/31/2022 - 2 years ago
  • Program Officer Name
    GLANTZ, MEYER
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/20/2021 - 3 years ago

Longitudinal Examination of Abstinence Maintenance and Relapse in Cigarette Smokers

Project Summary: Approximately ?fteen percent of individuals in the US smoke cigarettes. Despite multiple attempts to quit, most smoking cessation attempt fails within one year. Predicting who will be unable to remain abstinent from smoking would improve cessation outcomes by providing objective feedback regarding relapse risk and allowing for more ef?cient allocation of relapse prevention resources. Our own pilot data and recent reviews of the literature suggest considerable promise in identifying biomarkers for relapse using neuroimaging approaches. While some studies have begun to investigate relapse prediction, few, if any studies have exam- ined the process of relapse or prolonged abstinence longitudinally after initial abstinence has been achieved. The focus of this proposal is to derive neuroimaging markers that prospectively predict subsequent relapse as well as to understand how the brain changes to support continued abstinence. To accomplish the aims of this project, 50 former smokers who have quit within the last three to six months will complete functional MRI scans of cognitive control, cue reactivity, and intrinsic connectivity at baseline and at 3-, 6-, and 9-month follow-up ses- sions to identify those biomarkers that are stable over time prior to relapse. Deriving neural predictors of future relapse among those individuals who have recently made a quit attempt could be extremely important for patient- treatment matching and/or differential allocation of resources based on risk for relapse. In addition, by identifying the changes that occur in brain function after recovery, it may be possible to target relevant networks with brain stimulation techniques.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R21
  • Administering IC
    DA
  • Application Type
    7
  • Direct Cost Amount
    125000
  • Indirect Cost Amount
    75625
  • Total Cost
    200625
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
    SCH ALLIED HEALTH PROFESSIONS
  • Funding ICs
    NIDA:200625\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    NPAS
  • Study Section Name
    Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section
  • Organization Name
    PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
  • Organization Department
    PSYCHOLOGY
  • Organization DUNS
    003403953
  • Organization City
    UNIVERSITY PARK
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    168021503
  • Organization District
    UNITED STATES